Unknown

Dataset Information

0

IL-15 superagonist/IL-15R?Sushi-Fc fusion complex (IL-15SA/IL-15R?Su-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas.


ABSTRACT: Interleukin (IL)-15-N72D superagonist-complexed with IL-15R?Sushi-Fc fusion protein (IL-15SA/IL-15R?Su-Fc; ALT-803) has been reported to exhibit significant anti-tumor activity in murine myeloma, rat bladder cancer, and murine glioblastoma models. In this study, we examined the immunomodulatory and anti-tumor effects of IL-15SA/IL-15R?Su-Fc in tumor-free and highly metastatic tumor-bearing mice. Here, IL-15SA/IL-15R?Su-Fc significantly expanded natural killer (NK) and CD8+ T cells. In examining NK cell subsets, the greatest significant increase was in highly cytotoxic and migrating (CD11b+, CD27hi; high effector) NK cells, leading to enhanced function on a per-cell basis. CD8+ T cell subset analysis determined that IL-15SA/IL-15R?Su-Fc significantly increased IL-15 responding memory (CD122+, CD44+) CD8+ T cells, in particular those having the innate (NKG2D+, PD1-) phenotype. In 4T1 breast tumor-bearing mice, IL-15SA/IL-15R?Su-Fc induced significant anti-tumor activity against spontaneous pulmonary metastases, depending on CD8+ T and NK cells, and resulting in prolonged survival. Similar anti-tumor activity was seen in the experimental pulmonary metastasis model of CT26 colon carcinoma cells, particularly when IL-15SA/IL-15R?Su-Fc was combined with a cocktail of checkpoint inhibitors, anti-CTLA-4 and anti-PD-L1. Altogether, these studies showed for the first time that IL-15SA/IL-15R?Su-Fc (1) promoted the development of high effector NK cells and CD8+ T cell responders of the innate phenotype, (2) enhanced function of NK cells, and (3) played a vital role in reducing tumor metastasis and ultimately survival, especially in combination with checkpoint inhibitors.

SUBMITTER: Kim PS 

PROVIDER: S-EPMC4941302 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas.

Kim Peter S PS   Kwilas Anna R AR   Xu Wenxin W   Alter Sarah S   Jeng Emily K EK   Wong Hing C HC   Schlom Jeffrey J   Hodge James W JW  

Oncotarget 20160301 13


Interleukin (IL)-15-N72D superagonist-complexed with IL-15RαSushi-Fc fusion protein (IL-15SA/IL-15RαSu-Fc; ALT-803) has been reported to exhibit significant anti-tumor activity in murine myeloma, rat bladder cancer, and murine glioblastoma models. In this study, we examined the immunomodulatory and anti-tumor effects of IL-15SA/IL-15RαSu-Fc in tumor-free and highly metastatic tumor-bearing mice. Here, IL-15SA/IL-15RαSu-Fc significantly expanded natural killer (NK) and CD8+ T cells. In examining  ...[more]

Similar Datasets

| S-EPMC5104912 | biostudies-literature
| S-EPMC5787870 | biostudies-literature
| S-EPMC5992862 | biostudies-literature
| S-EPMC1482584 | biostudies-literature
| S-EPMC5916319 | biostudies-literature
| S-EPMC4703482 | biostudies-literature
| S-EPMC6337786 | biostudies-literature
| S-EPMC7032639 | biostudies-literature
| S-EPMC6089612 | biostudies-literature
| S-EPMC6326360 | biostudies-literature